Daluyon, Arlyn O.

HRN: 23-94-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2023
CEFTRIAXONE 1G (VIAL)
11/04/2023
11/11/2023
IV
2g
Q24
Bilateral Effusion, CAP-MR
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: